Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1974-10-30
1976-11-16
Meyers, Albert T.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424 12, 424 85, 424 88, A61K 3900, G01N 3122, G01N 3316
Patent
active
039925161
ABSTRACT:
A Pneumocystis carinii antiserum conjugated with fluorescein isothiocyanate composition, its use being the detection of Pneumocystis carinii organisms and the method of making this composition using an enzyme purifying technique.
REFERENCES:
lim; S., Applied Microbiology, vol. 26, Nov. 1973, pp. 666-671.
Kim; H., PSEBM, vol. 141, Oct. 1972, pp. 304-309.
Goldstein, J. Exptl. Med., vol. 114, 1961, pp. 89-109.
Kwapinski, Method of Immunocheim & Immunol. Res. Wiley-Interscience NY 1972, pp. 18-21, 609-610.
Fagelson A. P.
Meyers Albert T.
Wray James C.
LandOfFree
Direct fluorescent antibody composition and method for P. Pneumo does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Direct fluorescent antibody composition and method for P. Pneumo, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Direct fluorescent antibody composition and method for P. Pneumo will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-671334